CelLBxHealth plc Stock
Stocks
CLBX
GB0034330679
Advanced Medical Equipment & Technology
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.477 GBX | +1.86% |
|
-1.53% | +34.27% |
| 07-07 | CelLBxHealth chief executive Collins to step down | AN |
| 07-07 | Cellbxhealth plc Announces Resignation of Peter Collins as Chief Executive Officer | CI |
| Market Cap | 16.48M 22.02M 19.31M 17.83M 31.23M 2.11B 31.86M 214M 83.29M 1.03B 82.69M 80.88M 3.58B | P/E 2025 * |
-0.25x | P/E 2026 * | -0.62x |
|---|---|---|---|---|---|
| Enterprise Value | 9.18M 12.27M 10.76M 9.93M 17.4M 1.17B 17.74M 119M 46.39M 575M 46.06M 45.05M 2B | EV / Sales 2025 * |
0.89x | EV / Sales 2026 * | 0.69x |
| Free-Float |
94.31% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: CelLBxHealth plc
| 16/10/25 | Angle names Peter Collins as interim CEO | AN |
| 28/05/25 | RBC cuts National Grid; Citigroup cuts South32 | AN |
| 23/01/25 | HSBC raises FirstGroup, Goldman cuts Ithaca | AN |
| 14/09/23 | JPMorgan ups Rio Tinto; Redburn likes Carnival | AN |
| 24/01/22 | Berenberg Initiates Angle With Buy Rating, Sets PT | MT |
| 1 day | +1.86% | ||
| 1 week | -1.53% | ||
| Current month | -3.15% | ||
| 1 month | -17.94% | ||
| 3 months | +64.11% | ||
| 6 months | +40.67% | ||
| Current year | +34.27% |
| 1 week | 1.41 | 1.67 | |
| 1 month | 1.3 | 1.9 | |
| Current year | 0.85 | 2.8 | |
| 1 year | 0.85 | 8 | |
| 3 years | 0.85 | 37.4 | |
| 5 years | 0.85 | 163.75 | |
| 10 years | 0.85 | 163.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sinéad Armstrong
DFI | Director of Finance/CFO | - | 01/01/1999 |
| Chief Tech/Sci/R&D Officer | - | 01/01/2025 | |
Karen Miller
CTO | Chief Tech/Sci/R&D Officer | - | 05/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jan Groen
CHM | Chairman | 67 | 22/05/2023 |
Klaas de Boer
BRD | Director/Board Member | 61 | 12/01/2026 |
| Director/Board Member | 61 | 12/01/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12-19 | Buy | Chairman | 5,000,000 | 1.5497% | ||
| 12-19 | Buy | Chief Executive Officer | 5,000,000 | 1.5497% | ||
| 12-19 | Buy | Chief Financial Officer | 2,500,000 | 0.7749% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.86% | -1.53% | -76.37% | -87.43% | 22.02M | ||
| -0.70% | -5.37% | +0.28% | -28.83% | 15.79B | ||
| -1.77% | -4.99% | +29.21% | +88.65% | 1.62B | ||
| +1.47% | -5.12% | -44.03% | -79.48% | 1.18B | ||
| +0.36% | -3.46% | -29.63% | +33.62% | 1.09B | ||
| +0.29% | -3.35% | -29.97% | -54.68% | 614M | ||
| -2.23% | -9.38% | -41.11% | -58.26% | 537M | ||
| +1.03% | +0.75% | +27.64% | -52.83% | 453M | ||
| -0.32% | +0.65% | -56.11% | -59.77% | 377M | ||
| +1.59% | -6.44% | -27.23% | -26.83% | 323M | ||
| Average | +0.16% | -3.06% | -24.73% | -32.58% | 2.2B | |
| Weighted average by Cap. | -0.54% | -3.75% | -4.19% | -22.30% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 10.35M 13.84M 12.14M 11.21M 19.63M 1.32B 20.02M 135M 52.34M 648M 51.96M 50.83M 2.25B | 21.65M 28.93M 25.38M 23.43M 41.04M 2.77B 41.86M 282M 109M 1.36B 109M 106M 4.71B |
| Net income | -16.35M -21.85M -19.16M -17.69M -30.99M -2.09B -31.61M -213M -82.64M -1.02B -82.05M -80.25M -3.55B | -8.55M -11.43M -10.02M -9.25M -16.21M -1.09B -16.53M -111M -43.22M -535M -42.91M -41.97M -1.86B |
| Net Debt | -7.3M -9.76M -8.56M -7.9M -13.84M -934M -14.11M -94.97M -36.9M -457M -36.64M -35.83M -1.59B | -1.6M -2.14M -1.88M -1.73M -3.03M -205M -3.09M -20.81M -8.09M -100M -8.03M -7.85M -348M |
Employees
119
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/07/26 | GBX 1.477 | +1.86% | 5,000 |
| 08/07/26 | GBX 1.450 | -1.69% | 2,251,058 |
| 07/07/26 | GBX 1.475 | -7.81% | 4,128,376 |
| 06/07/26 | GBX 1.600 | +6.67% | 2,912,628 |
| 03/07/26 | GBX 1.500 | 0.00% | 716,727 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0145GBP
Average target price
0.0400GBP
Spread / Average Target
+175.86%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CLBX Stock
Select your edition
All financial news and data tailored to specific country editions

















